Rights and permissions
About this article
Cite this article
The development of candidate HIV vaccines is expected to accelerate with 4 new partnerships between the private and public sectors announced by the US National Institute of Allergy and Infectious Diseases (NIAID). Inpharma Wkly. 1245, 4 (2000). https://doi.org/10.2165/00128413-200012450-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200012450-00003